UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Identify which index fund to hold after IRA rollover 2024 by weighing cost, simplicity, and diversification. Get practical guidance for a solid retirement stance.
26,517 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Bitcoin climbs back above key levels as ETF inflows resume and institutions accumulate, fueling a broad crypto-market...
A surge in Planet Labs shares has traders buzzing. This guide explains the drivers behind the move, the risks involve...
Rent the Runway announces that Jenn Hyman will step down as CEO, with a transition plan that keeps her involved as an...
As GLP-1 therapies reshape obesity treatment, investors eye the best weight loss drug stock bets for 2026. This guide...
Meta Platforms stock crushed the market today as Meta rolled out a business-focused AI tool worldwide. Investors weig...
Investors are weighing the fate of the retiring cruise ship dream as the cruise industry rebounds. The reality check:...
A Gen Z graduate turns a conference waitressing gig into a LinkedIn job, then climbs to Google, highlighting how in-p...
A widespread fraud targeted older Americans by posing as Publishers Clearing House winners. Federal investigators say...
A meme token surged 80% in a single day, positioning itself as a top contender in the meme-coin space and challenging...
The CLARITY Act failed to hit its July 4 milestone. With August 7 looming, Senate leadership faces a narrow window to...
As vernova's next earnings report approaches, traders and long-term investors weigh margin trends, project momentum, ...